TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) Revenue 2016–2025
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$17.3BFY2025 · since FY2016: $21.9B → $17.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $17.3B | +4.3% |
| FY2024 | $16.5B | +4.4% |
| FY2023 | $15.8B | +6.2% |
| FY2022 | $14.9B | -6.0% |
| FY2021 | $15.9B | -4.7% |
| FY2020 | $16.7B | -1.4% |
| FY2019 | $16.9B | -7.6% |
| FY2018 | $18.3B | -16.4% |
| FY2017 | $21.9B | -0.2% |
| FY2016 | $21.9B | — |
Source: SEC XBRL filings · For reference only · Not investment advice